Revvity (NYSE:RVTY) Stock Acquired Rep. Gilbert Ray Cisneros, Jr.

Key Points

• Representative Gilbert Ray Cisneros, Jr. purchased shares of Revvity Inc. (NYSE:RVTY) valued between $1,001 and $15,000 on July 23rd, with the transaction occurring in an account managed by Bank of America.
• Revvity reported a quarterly earnings per share (EPS) of $1.18, surpassing analysts' expectations of $1.14, with revenue of $720.28 million for the quarter, up 4.1% from the previous year.
• The company also announced a quarterly dividend of $0.07 per share, scheduled for payment on November 7th, representing a 0.3% yield based on current valuation.

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Revvity Inc. (NYSE:RVTY). In a filing disclosed on August 14th, the Representative disclosed that they had bought between $1,001 and $15,000 in Revvity stock on July 23rd. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of W.R. Berkley NYSE: WRB on 7/31/2025.
• Purchased $1,001 - $15,000 in shares of CoStar Group NASDAQ: CSGP on 7/31/2025.
• Purchased $1,001 - $15,000 in shares of Dayforce NYSE: DAY on 7/31/2025.
• Sold $1,001 - $15,000 in shares of Boston Scientific NYSE: BSX on 7/31/2025.
• Sold $1,001 - $15,000 in shares of Medpace NASDAQ: MEDP on 7/24/2025.
• Sold $1,001 - $15,000 in shares of Avantor NYSE: AVTR on 7/23/2025.
• Purchased $1,001 - $15,000 in shares of Gulfport Energy NYSE: GPOR on 7/18/2025.
• Purchased $1,001 - $15,000 in shares of Ultragenyx Pharmaceutical NASDAQ: RARE on 7/15/2025.
• Purchased $1,001 - $15,000 in shares of PTC NASDAQ: PTC on 7/9/2025.
• Purchased $1,001 - $15,000 in shares of Robinhood Markets NASDAQ: HOOD on 7/9/2025.

Revvity Stock Performance

NYSE:RVTY traded up $4.6450 during midday trading on Friday, reaching $94.3150. The stock had a trading volume of 199,323 shares, compared to its average volume of 1,174,810. The company has a debt-to-equity ratio of 0.43, a current ratio of 3.33 and a quick ratio of 2.75. Revvity Inc. has a 1-year low of $85.12 and a 1-year high of $129.50. The firm's fifty day simple moving average is $94.56 and its 200-day simple moving average is $99.25. The stock has a market capitalization of $10.95 billion, a P/E ratio of 39.99, a PEG ratio of 2.46 and a beta of 0.91.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Monday, July 28th. The company reported $1.18 earnings per share for the quarter, beating analysts' consensus estimates of $1.14 by $0.04. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The firm had revenue of $720.28 million during the quarter, compared to the consensus estimate of $711.26 million. During the same period in the prior year, the firm earned $1.22 EPS. The business's revenue was up 4.1% on a year-over-year basis. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. On average, equities research analysts forecast that Revvity Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 17th will be paid a $0.07 dividend. The ex-dividend date is Friday, October 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity's dividend payout ratio (DPR) is presently 11.86%.

Analyst Ratings Changes

RVTY has been the subject of a number of research reports. JPMorgan Chase & Co. reduced their price target on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a report on Tuesday, April 29th. Raymond James Financial reissued an "outperform" rating and issued a $115.00 price target (down from $120.00) on shares of Revvity in a report on Tuesday, July 29th. Evercore ISI reduced their price target on shares of Revvity from $116.00 to $115.00 and set an "outperform" rating for the company in a report on Tuesday, July 8th. The Goldman Sachs Group reduced their price target on shares of Revvity from $140.00 to $125.00 and set a "buy" rating for the company in a report on Tuesday, April 29th. Finally, Stifel Nicolaus reduced their price target on shares of Revvity from $120.00 to $110.00 and set a "hold" rating for the company in a report on Tuesday, July 29th. Ten equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $120.07.

Hedge Funds Weigh In On Revvity

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Revvity by 8.5% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 22,515,711 shares of the company's stock worth $2,382,163,000 after acquiring an additional 1,754,403 shares during the period. Vanguard Group Inc. lifted its holdings in shares of Revvity by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 14,382,849 shares of the company's stock worth $1,521,705,000 after acquiring an additional 92,638 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in shares of Revvity by 25.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 9,563,911 shares of the company's stock worth $1,011,863,000 after acquiring an additional 1,932,314 shares during the period. EdgePoint Investment Group Inc. increased its position in shares of Revvity by 26.7% during the 2nd quarter. EdgePoint Investment Group Inc. now owns 6,789,660 shares of the company's stock worth $656,696,000 after purchasing an additional 1,428,813 shares in the last quarter. Finally, Janus Henderson Group PLC increased its position in shares of Revvity by 0.4% during the 4th quarter. Janus Henderson Group PLC now owns 6,358,952 shares of the company's stock worth $709,725,000 after purchasing an additional 23,650 shares in the last quarter. 86.65% of the stock is owned by institutional investors.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.